Mammographic screening: no reliable supporting evidence?
Saved in:
| Title: | Mammographic screening: no reliable supporting evidence? |
|---|---|
| Authors: | Miettinen, Olli S, Henschke, Claudia I, Pasmantier, Mark W, Smith, James P, Libby, Daniel M, Yankelevitz, David F |
| Source: | Lancet. 2/2/2002, Vol. 359 Issue 9304, p404. 2p. 1 Graph. |
| Subjects: | Mammograms, Cancer-related mortality, Medical screening, Health risk assessment |
| Abstract: | Much confusion is being generated by the conclusion of a recent review that "there is no reliable evidence that screening for breast cancer reduces mortality." In that review, however, there was no appreciation of the appropriate mortality-related measure of screening's usefulness; and correspondingly, there was no estimation of the magnitude of this measure. We take this measure to be the proportional reduction in case-fatality rate, and studied its magnitude on the basis of the only valid and otherwise suitable trial. We found reliable evidence of fatality reduction, apparently substantial in magnitude. [ABSTRACT FROM AUTHOR] |
| Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Much confusion is being generated by the conclusion of a recent review that "there is no reliable evidence that screening for breast cancer reduces mortality." In that review, however, there was no appreciation of the appropriate mortality-related measure of screening's usefulness; and correspondingly, there was no estimation of the magnitude of this measure. We take this measure to be the proportional reduction in case-fatality rate, and studied its magnitude on the basis of the only valid and otherwise suitable trial. We found reliable evidence of fatality reduction, apparently substantial in magnitude. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 01406736 |
| DOI: | 10.1016/S0140-6736(02)07592-X |
